Interventions: Participants were managed within the Case Management Service in accordance with usual pathways.
patients along locally implemented pathways. A number of benefits of this type of service have been reported including: a reduction in unnecessary referrals to secondary care 5, 6 ; enhanced patient satisfaction 7, 8 improved surgical conversion rates, 7 and improved patient reported outcomes including generic health status and pain. 8 In 2011, over 80 000 of the 2.5 million clients of one UK private healthcare provider were treated for back pain. In response to the large number of people requiring assessment and treatment of back pain, a specialised service was required. Thus, the MCAS model was adapted for the private sector and a Case Management Service (CMS), led by physiotherapists, was developed. In contrast to the MCAS service, the CMS was telephone based.
The aim of the CMS was for clients with back pain to receive fast access to advice and the appropriate treatment at the right time. Client assessment was undertaken by a Case Manager using a detailed telephone assessment along with the referring physiotherapist's documentation for the objective assessment. The Case Manager, based within the private insurance provider setting, had an overview of the client's treatment pathway, insurance policy benefits and clinical presentations. Their role was to facilitate early access to consultants, when necessary; reduce unnecessary diagnostics and surgical referrals, as recommended in the Musculoskeletal Services Framework 9 ; and reduce over-treatment with non-evidence based practice. It was therefore anticipated that the CMS should improve patient outcomes while potentially decreasing the total overall cost of treatment.
However, CMS is a relatively new area for musculoskeletal physiotherapists to be involved in within the UK. Moreover, the clinical and cost-effectiveness of a physiotherapy led CMS in the UK private sector has not been documented. Due to differences between private and public healthcare sectors in terms of access and service delivery, the NHS based literature may not be transferable to the private sector. Therefore, the aim of this study was to evaluate the clinical-effectiveness and resource use associated with Case Management Services in a UK private sector.
| METHODOLOGY Design
An observational cohort study was undertaken to investigate the aim of this study. This was based on prospective data collection of patient reported outcome measures (PROMs) and data collection from an existing administrative health database of a UK private healthcare provider. This study is presented in accordance with SQUIRE guidelines. 10 Ethical Approval was obtained for the study from the Manchester Metropolitan University Ethics Committee. Additionally, management approval was obtained from the national provider of private healthcare.
| Participants
Consecutive referrals to the CMS over a three-month period were entered into the evaluation. Participants were identified through their medical records. They were included in the study if they had previously received a minimum of six sessions of therapy and had failed to respond positively to treatment prior to referral to the CMS. The participants were aged over 18 years with no upper age limit. Participants who were not able to communicate in English, or demonstrated difficulties with telephone communication, were excluded from the study. Participants were also excluded from pre and post PROM collection if at initial assessment they required advice only and no ongoing input, however, they were included in the satisfaction survey.
| Outcome measures
Functional ability was examined using the Patient Specific Functional Scale (PSFS). This has been designed for assessing functional change in patients with musculoskeletal disorders and has been found to be valid and responsive to change in this population. 11, 12 The PSFS is scored between 0 and 10 for each activity that is limited by the condition for which the client is seeking treatment; 10 being no problems and zero being unable to perform the activity. The overall PSFS score is an average of all activity scores.
QoL was examined, using EQ-5D-5L, a generic PROM, that has been shown to be reliable and valid for musculoskeletal conditions 3,13 and adopted for use by the UK National PROMs programme. Patient perceived improvement was assessed using EQ-VAS which is an integral component of the EQ-5D-5L and is recognised as being clinically relevant when taken alongside PROMs and patient satisfaction.
14,15
The Consultant and Relational Empathy (CARE) measure is a patient reported experience measure (PREM), which examines the patient's experience of the consultation process and is recommended by the Chartered Society of Physiotherapy (CSP) for use in physiotherapy services. 13 It measures empathy in the context of the therapeutic relationship during a one-on-one consultation and can be used to assess client satisfaction. 16 The questionnaire consists of ten questions concerning the performance of the therapist, and is rated on a scale from 1 (poor) to 5 (excellent) with a maximum total score of 50 and a minimum of 10. A higher score indicates a greater perception of therapist empathy and satisfaction.
The CARE measure has been found to have face and content validity with high internal reliability and to be stable across different socio-economic patient groups. 16 
| Cost Consequences analysis
Cost consequences analysis, a method of economic evaluation with incremental costs reported separately to other outcomes. 17 The analysis was completed using an existing dataset extracted from an administrative database, by selecting all claims data (including cost of:
therapies, consultant appointments, investigations and injections) for adults with a primary diagnosis of back or spinal pain over an 11-month period from the total lives covered. Data was coded and anonymised for analysis.
| Procedure
At initial assessment the Case Manager completed outcome measures:
PSFS and EQ-5D-5L, verbally over the phone as per usual Case
Management process. The client was then managed within the service in accordance with usual CMS pathways. At the point at which the client's case was closed, repeat outcome measures: PSFS and EQ-5D-5L were taken and the CARE satisfaction questionnaire was distributed.
| Data Analysis
Descriptive statistics were used to summarise patient demographics.
Where data was normally distributed, means and standard deviation (SD) were used; however, median and interquartile range were used for non-normally distributed data. Changes between baseline and follow-up, for all health outcomes data were assessed using Wilcoxon
Signed Rank test. The significant value set was p < 0.05. The correlation between PSFS change and chronicity of symptoms was assessed using Spearman rho correlation analysis.
Descriptive analysis was used for cost consequences evaluation.
The analysis was used as a description of overall and itemised cost of resource use within back care. The analysis was completed for January to November 2011; pre-CMS implementation, and during the same period, January to November 2014; post-CMS implementation.
| RESULTS
One hundred and ten clients were referred to the study, 62 of whom completed the full set of outcome measures ( Figure 1 ). Of the 62 participants, 43 were female. The mean age of the participants was 45.73 (SD 12.02) and mean chronicity of symptoms was 16.93 months (SD 50.64).
Following CMS there was a statistically significant improvement in QoL (p < 0.0001). There were also significant improvements in perceived improvement score and function (both p < 0.0001), following the CMS (Table 1) . There was a weak correlation between chronicity of symptoms at point of referral and PSFS outcome (r = 0.201; p = 0.106).
| Patient Reported Experience Measure
Ninety-six percent of the sample rated their Case Management experience as between good and excellent showing a high level of satisfaction with the CMS (Figure 2 ).
| Cost Consequences
An analysis of the cost consequences data examining the total number of therapy sessions provided for clients between January and November in 2014, two years after CMS implementation, compared to January to November in 2011, prior CMS development are presented in Table 2 .
From the total number of clients in 2011, 3.12% of clients received treatment for their back complaint (Table 2 ). In 2014, whilst the total number of clients had decreased by 13%, the percentage of (Table 3) . Referrals for MRI scans also increased from 18% to 23%. The total lives covered decreased slightly from 2011 to 2014 (Table 3) .
| DISCUSSION
The aim of this study was to evaluate a CMS, in terms of effectiveness on health outcomes and patient satisfaction. It also examined the resource use of the CMS. The key findings were that health outcomes significantly improved following CMS with high levels of participant satisfaction. The CMS was also associated with reduced therapy resource use.
It was found that the health outcomes measured, showed significant improvement in QoL and functional ability following CMS intervention. The minimum clinically important difference (MCID) for the PSFS is considered to be 2 points. 18 The mean change in PSFS post-CMS was 1.98, and therefore is approaching a clinically significant FIGURE 1 Recruitment and progress through study chronicity of symptoms and health outcomes, found no correlation between the duration of symptoms at baseline and improvement in QoL and function, post intervention. This contrasts to other studies who found increased chronicity of symptoms, to be a predictor of poor outcomes. 8 However, this may be related to the chronicity in this study being relatively low (17 months) compared to other studies (45 months). 8 The CARE measure, found 96% of clients rated the CMS as good to excellent, thus indicating their satisfaction with the service.
The CARE measure score has been found to be predictive of enablement and health changes following consultation across a wide range of chronic conditions. 20 to align the service with current NICE guidance 22 which suggests that 85% of back pain is non-specific low back pain and should be managed conservatively.
It has been found that 30% of the UK population will suffer from back pain in one year. 2 Of these, 20% will seek GP advice, which is double the percentage of clients in this study seeking treatment for back pain, 3.6%. This specific client group of private policy holders may account for the differences to the national UK population as previously mentioned. In this study, the number of clients attending a consultant appointment had increased from 80% in 2011 to 88% in 2014 and following on from this MRI scans delivered has also increased. The total lives covered decreased slightly from 2011 to 2014, and resource use increased by approximately £2 million (see Table 3 ). This increase can be accounted for by the rising spend on MRI scans almost exactly. Referral for MRI had increased by 3.5% over the observed period. If the MRI cost is excluded in resources use, then the total overall spend only increased by £28 364 which equates an increase of 0.08%.
There were some limitations to this study. The response rates for the clinical data (56%) and CARE postal questionnaire (24%) were low and, may have impacted on the findings of the present study. Future research should give due consideration to participant engagement strategies, such as follow-up telephone and email contact. Additionally, satisfaction questionnaire collection may benefit from an online template to allow a less demanding process for the respondent. This study did not investigate the long-term effectiveness of CMS, therefore, it is recommended that a 12-month follow-up for repeat outcome measures could be undertaken to assess maintenance of this improvement. This evaluation has provided evidence to demonstrate quality in healthcare, including patient satisfaction and improved patient reported outcome measures. Following the successful outcomes of the CMS for back care, consideration should be given to extending this service to other musculoskeletal conditions.
| CONCLUSION
The clinical and economic evaluation of a UK private sector CMS,
showed the provision to be providing significant improvement in health outcomes in terms of quality of life and function, as well as delivering a service that 96% of users rated as good to excellent.
There was also a reduction in overall therapy resource use in the period after the development of the CMS. This is largely due to the reduction in sessional average per client. These results suggest that this model of managing low back pain is cost-effective and provide economic benefit to insurance providers, and subsequently members via policy subscriptions, as well as providing a clinically effective pathway for back pain.
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